Loading company…
Brisbane-based biotechnology company offering microbiome diagnostics, including the MetaPanel and MetaXplore platforms for gut microbiome analysis.
Microba Life Sciences Limited was founded in 2018 in Brisbane, Australia, and develops microbiome analysis and diagnostics. Its MetaPanel and MetaXplore platforms analyze gut microbiome composition for clinicians, researchers and individuals, with a focus on inflammatory bowel disease and autoimmune disorders. The company reported revenue of USD 3.65 mn and EBITDA of USD -7.98 mn in 2023. It has completed 6 deals, and its most recent, on November 29, 2022, was a trade sale led by Sonic Healthcare Limited that raised USD 17.8 mn. Gene Tyson is the founder and Luke Reid is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in